Aurinia Pharmaceuticals Inc’s recent filing unveils that its Director TANG KEVIN acquired Company’s shares for reported $10.12 million on Aug 01 ’25. In the deal valued at $10.12 per share,1,000,000 shares were bought. As a result of this transaction, TANG KEVIN now holds 11,029,500 shares worth roughly $125.41 million.
Then, TANG KEVIN bought 200,000 shares, generating $2,336,000 in total proceeds. Upon buying the shares at $11.68, the Director now owns 11,329,500 shares.
Before that, TANG KEVIN bought 100,000 shares. Aurinia Pharmaceuticals Inc shares valued at $1,134,000 were divested by the Director at a price of $11.34 per share. As a result of the transaction, TANG KEVIN now holds 11,129,500 shares, worth roughly $126.54 million.
A number of analysts have revised their coverage, including Oppenheimer’s analysts, who decreased its forecast for the stock in early November from “an Outperform” to “a Perform”. Oppenheimer revised its rating on December 10, 2021. It rated AUPH as “an Outperform” which previously was an “a Perform”.
Price Performance Review of AUPH
On Friday, Aurinia Pharmaceuticals Inc [NASDAQ:AUPH] saw its stock fall -0.52% to $11.37. Over the last five days, the stock has gained 8.39%. Aurinia Pharmaceuticals Inc shares have risen nearly 102.31% since the year began. Nevertheless, the stocks have risen 26.61% over the past one year.
How much short interest is there in Aurinia Pharmaceuticals Inc?
A steep rise in short interest was recorded in Aurinia Pharmaceuticals Inc stocks on 2025-07-15, growing by 96414.0 shares to a total of 10.63 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-13 was 10.53 million shares. There was a rise of 0.91%, which implies that there is a positive sentiment for the stock.
